Segment Information - Summary of Net Sales and Operating Profit by Segment (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net Sales And Operating Profit Information [Line Items]
Net Sales	$ 1,924.0	$ 1,929.3	$ 5,798.3	$ 4,939.2
Operating Profit	214.9	299.2	701.0	(328.5)
Intangible asset amortization	(153.7)	(149.7)	(463.8)	(445.0)
Restructuring and other cost reduction initiatives	(23.5)	(16.2)	(64.9)	(89.2)
Quality remediation	(11.8)	(9.8)	(33.0)	(35.9)
Acquisition, integration, divestiture and related	(27.3)	(9.1)	(66.1)	(15.7)
Goodwill and intangible asset impairment			(16.3)	(645.0)
EMEA [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	393.1	366.2	1,207.1	983.0
Asia Pacific [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	350.4	346.6	1,056.1	904.7
Corporate Functions [Member]
Net Sales And Operating Profit Information [Line Items]
Operating Profit	(151.2)	(181.3)	(469.6)	(574.7)
Operating Segments [Member] | Americas Orthopedics [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	1,009.4	1,033.2	3,013.9	2,602.7
Operating Profit	422.2	452.1	1,254.7	1,059.1
Operating Segments [Member] | EMEA [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	366.2	339.7	1,108.2	915.1
Operating Profit	88.3	84.6	269.8	213.5
Operating Segments [Member] | Asia Pacific [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	339.9	336.0	1,022.5	876.4
Operating Profit	114.7	113.4	346.4	284.4
Operating Segments [Member] | Americas Spine and Global Dental [Member]
Net Sales And Operating Profit Information [Line Items]
Net Sales	208.5	220.4	653.7	545.0
Operating Profit	27.8	39.3	106.9	61.8
Segment Reconciling Items [Member]
Net Sales And Operating Profit Information [Line Items]
Inventory and manufacturing-related charges	(11.0)	(2.3)	(13.0)	(4.3)
Intangible asset amortization	(153.7)	(149.7)	(463.8)	(445.0)
Restructuring and other cost reduction initiatives	(23.3)	(16.2)	(64.9)	(89.2)
Quality remediation	(11.8)	(10.0)	(33.0)	(35.8)
Acquisition, integration, divestiture and related	(27.3)	(9.1)	(66.1)	(15.7)
Litigation	(43.6)	(19.3)	(53.3)	(100.4)
European Union Medical Device Regulation	(11.9)	(2.0)	(29.4)	(19.1)
Other charges	$ (4.3)	$ (0.3)	(2.4)	(18.1)
Goodwill and intangible asset impairment			(16.3)	$ (645.0)
Certain R&D agreements			$ (65.0)